StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.78+0.01 (+0.36%)

Close on Nov 17, 2026Market cap $23.19MP/E –Yield –

Evaxion A/S market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Evaxion A/S's market cap was $18.65M on Nov 11, 2026, against $6.37M a year earlier. Over the last 4 years it ranged from $1.06M to $36.78M, with a median of $9.29M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$18.65M+264.4%
2025Dec 31, 2025$5.12M+121.5%
2024Dec 31, 2024$2.31M-85.7%
2023Dec 29, 2023$16.21M–

More Evaxion A/S figures

See a number that looks wrong?